Your browser doesn't support javascript.
loading
Melatonin as a complementary and prophylactic agent against COVID-19 in high-risk populations: A narrative review of recent findings from clinical and preclinical studies.
Hosseini, Abdolkarim; Badri, Taleb; Esmaeili Gouvarchin Ghaleh, Hadi; Hassanpour, Kazem; Alishiri, Gholamhossein; Akbariqomi, Mostafa; Farnoosh, Gholamreza.
Afiliación
  • Hosseini A; Department of Animal Sciences and Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran.
  • Badri T; Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Esmaeili Gouvarchin Ghaleh H; Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Hassanpour K; Department of Pediatric, School of Medicine, Sabzevar University of Medical Sciences, Sabzevar, Iran.
  • Alishiri G; Chemical Injuries Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Akbariqomi M; Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
  • Farnoosh G; Applied Biotechnology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Fundam Clin Pharmacol ; 36(6): 918-929, 2022 Dec.
Article en En | MEDLINE | ID: mdl-35567287
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Melatonina Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Fundam Clin Pharmacol Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tratamiento Farmacológico de COVID-19 / Melatonina Tipo de estudio: Diagnostic_studies / Etiology_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Fundam Clin Pharmacol Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido